World Conference on Lung Cancer 2021 Highlights

IASLC Webinars

In this recorded webinar, join Drs. Harpole, Higgins, and Stinchcombe as they discuss the latest developments presented during the scientific and educational program at 2021 World Conference on Lung Cancer Worldwide Virtual Event. The webinar is three 15 minute presentations followed by a 15 minute time for question and answers.

Target Audience

This webinar is designed to meet the educational needs of physicians, nurses and allied health professionals, pharmacists, patient advocates, and researchers who specialize in diagnostic radiology, hematology, pulmonary medicine, palliative care, medical oncology, thoracic surgery, and radiation oncology. 

Learning Objectives

At the conclusion of this activity, participants will be able to:

  1. Describe scientific progress in the prevention, early detection, diagnosis and treatment of thoracic malignancies.
  2. Explain advances in the multidisciplinary management of patients in relation to current standards of care.
  3. Identify the most relevant clinical research results and ongoing trials likely to impact patient care in the near future.
Course summary
Available credit: 
  • 1.00 Attendance
Course opens: 
Course expires: 

Daniel Tan:

Advisory Board: Novartis, Bayer, Boehringer Ingelheim, Astra Zeneca, Eli-lily, Loxo, Pfizer, MSD. Contracted/Support research grant: Novartis, Astra Zeneca, GlaxoSmithKline, Bayer, Pfizer.

Yi-long Wu:

Advisory Board: AstraZeneca, Boehringer Ingelheim. Honorarium received from promotional activities: AstraZeneca, Roche, Boehringer Ingelheim, Pfizer, BMS, MSD, Eli Lilly (all not promotional activities). Contracted/Support Research Grant: AstraZeneca, Roche, Boehringer Ingelheim. 

Ross Soo:

Contracted/Support research grant: AstraZeneca, and Boehringer Ingelheim. Personal fees: Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer,Roche, Taiho, Takeda, Yuhan, Amgen.

None of the other individuals involved in the planning or review of the activity have disclosed any relevant financial relationships.

Yi-Long Wu


Yi-long Wu, MD
Head of Department
Guangdong Lung Cancer Institute
Guangdong General Hospital and Guangdong Academy of Medical Sciences


Daniel Tan

Daniel SW Tan, MD 
Senior Consultant
Division of Medical Oncology 
National Cancer Centre Singapore


Ross Soo

Ross Soo, MBBS, RACP
Senior Consultant at the Department of Haematology-Oncology, NCIS
Adjunct Principal Investigator, Cancer Science Institute of Singapore, NUS

AMA PRA Category 1 Credit™ is no longer available for this activity.

Available Credit

  • 1.00 Attendance


Please login or register to take this course.